Annual General Meeting of BB BIOTECH AG: Shareholders approve all proposals of Board of Directors
(Thomson Reuters ONE) -
BB BIOTECH AG / Annual General Meeting of BB BIOTECH AG: Shareholders approve all proposals of Board of Directors processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
Press release of March 29, 2010
At the Annual General Meeting of March 29, 2010, the shareholders approved all
the proposals submitted by the Board of Directors.
The shareholders approved the payout of a cash dividend of CHF 3.70 per
registered share for fiscal 2009. The past President of the Board of Directors,
Prof. Dr. Thomas Szucs M.D. as well as the members of the Board of Directors,
Prof. Dr. David Baltimore and Dr. Clive Meanwell, were re-elected for a further
term of office.
Further particulars:
Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht, Switzerland
Thomas Egger, phone +41 44 267 67 09, teg(at)bellevue.ch
Company profile
BB BIOTECH invests in companies in the fast growing market of biotechnology and
is one of the world's largest investors with CHF 1.5 bn asset under management
in this sector. BB BIOTECH is listed in Switzerland, Germany and Italy. Its
investments are focused on listed companies that are developing and
commercializing novel medical treatments and cures. BB BIOTECH's investment
selection process is guided by the fundamental research and analysis of
physicians and molecular biologists. Its Board of Directors has many years of
experience in industry and science.
[HUG#1398376]
--- End of Message ---
BB BIOTECH AG
Vordergasse 3 Schaffhausen Switzerland
WKN: AONFN3;ISIN: CH0038389992;
Press Release_EN_PDF: http://hugin.info/130285/R/1398376/354181.pdf
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.03.2010 - 12:01 Uhr
Sprache: Deutsch
News-ID 1012138
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Schaffhausen
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 233 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Annual General Meeting of BB BIOTECH AG: Shareholders approve all proposals of Board of Directors
"
steht unter der journalistisch-redaktionellen Verantwortung von
BB BIOTECH AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
